(r)HDL in theranostics: how do we apply HDL's biology for precision medicine in atherosclerosis management?dagger


Por: Uribe, KB, Benito-Vicente, A, Martin, C, Blanco-Vaca, F, Rotllan, N

Publicada: 7 may 2021 Ahead of Print: 1 mar 2021
Resumen:
High-density lipoproteins (HDL) are key players in cholesterol metabolism homeostasis since they are responsible for transporting excess cholesterol from peripheral tissues to the liver. Imbalance in this process, due to either excessive accumulation or impaired clearance, results in net cholesterol accumulation and increases the risk of cardiovascular disease (CVD). Therefore, significant effort has been focused on the development of therapeutic tools capable of either directly or indirectly enhancing HDL-guided reverse cholesterol transport (RCT). More recently, in light of the emergence of precision nanomedicine, there has been renewed research interest in attempting to take advantage of the development of advanced recombinant HDL (rHDL) for both therapeutic and diagnostic purposes. In this review, we provide an update on the different approaches that have been developed using rHDL, focusing on the rHDL production methodology and rHDL applications in theranostics. We also compile a series of examples highlighting potential future perspectives in the field.

Filiaciones:
Uribe, KB:
 Basque Res & Technol Alliance BRTA, Ctr Cooperat Res Biomat CIC BiomaGUNE, Paseo Miramon 182, Donostia San Sebastian 20014, Spain

Benito-Vicente, A:
 CSIC, Inst Biofis UPV EHU, Apdo 644, Bilbao 48080, Spain

 Univ Basque Country, Dept Bioquim, Apdo 644, Bilbao 48080, Spain

Martin, C:
 CSIC, Inst Biofis UPV EHU, Apdo 644, Bilbao 48080, Spain

 Univ Basque Country, Dept Bioquim, Apdo 644, Bilbao 48080, Spain

Blanco-Vaca, F:
 Hosp Santa Creu & St Pau Inst Invest Biomed IIB S, Serv Bioquim, Barcelona 08041, Spain

 CIBER Diabet & Enfermedades Metab Asociadas CIBER, Barcelona, Spain

 Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain

 Inst Invest Biomed IIB St Pau, Inst Recerca Hosp Santa Creu & St Pau, Barcelona 08025, Spain

Rotllan, N:
 CIBER Diabet & Enfermedades Metab Asociadas CIBER, Barcelona, Spain

 Inst Invest Biomed IIB St Pau, Inst Recerca Hosp Santa Creu & St Pau, Barcelona 08025, Spain
ISSN: 20474830
Editorial
ROYAL SOC CHEMISTRY, THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND, Reino Unido
Tipo de documento: Review
Volumen: 9 Número: 9
Páginas: 3185-3208
WOS Id: 000631720000001
ID de PubMed: 33949389
imagen Green Published, hybrid

MÉTRICAS